Meriwether Wealth & Planning’s Jazz Pharmaceuticals JAZZ Stock Holding History

Meriwether Wealth & Planning’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.4K	Buy	+45	New	+$11.1K	﹤0.01%	415

Other funds holding JAZZ

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Meriwether Wealth & Planning's JAZZ Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 45 shares worth $10.4K. The stake represents ﹤0.01% of the portfolio and ranks #415 among its holdings.

189 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

Meriwether Wealth & Planning held 45 shares of Jazz Pharmaceuticals worth $10.4K as of Q3 2026.
Jazz Pharmaceuticals was a new Meriwether Wealth & Planning position in Q3 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #415 holding.
189 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.